About Medizinische Universität Wien; Universitätsklinik für Augenheilkunde und Optometrie
Clinical Trials at Medizinische Universität Wien; Universitätsklinik für Augenheilkunde und Optometrie
During the past decade, Medizinische Universität Wien; Universitätsklinik für Augenheilkunde und Optometrie conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 4 clinical trials were completed, i.e. on
average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 4 clinical trials were completed. i.e. 66.7%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Medizinische Universität Wien; Universitätsklinik für Augenheilkunde und Optometrie"
#1 collaborator was "Chugai Pharmaceutical" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Medizinische Universität Wien; Universitätsklinik für Augenheilkunde und Optometrie
According to Clinical.Site data, the most researched conditions in "Medizinische Universität Wien; Universitätsklinik für Augenheilkunde und Optometrie" are
"Geographic Atrophy" (3 trials), "Diabetic Macular Edema" (2 trials), "Central Retinal Vein Occlusion" (1 trials), "Efficacy, Self" (1 trials) and "Glaucoma" (1 trials). Many other conditions were trialed in "Medizinische Universität Wien; Universitätsklinik für Augenheilkunde und Optometrie" in a lesser frequency.
Clinical Trials Intervention Types at Medizinische Universität Wien; Universitätsklinik für Augenheilkunde und Optometrie
Most popular intervention types in "Medizinische Universität Wien; Universitätsklinik für Augenheilkunde und Optometrie" are "Drug" (8 trials), "Other" (4 trials), "Procedure" (3 trials) and "Device" (2 trials). Other intervention types were less common.
The name of intervention was led by "Faricimab" (5 trials), "Sham Procedure" (5 trials), "Aflibercept" (3 trials), "Lampalizumab" (2 trials) and "No intervention" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Medizinische Universität Wien; Universitätsklinik für Augenheilkunde und Optometrie
The vast majority of trials in "Medizinische Universität Wien; Universitätsklinik für Augenheilkunde und Optometrie" are
11 trials for "All" genders.
Clinical Trials Status at Medizinische Universität Wien; Universitätsklinik für Augenheilkunde und Optometrie
Currently, there are NaN active trials in "Medizinische Universität Wien; Universitätsklinik für Augenheilkunde und Optometrie".
undefined are not yet recruiting,
2 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Medizinische Universität Wien; Universitätsklinik für Augenheilkunde und Optometrie,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Medizinische Universität Wien; Universitätsklinik für Augenheilkunde und Optometrie, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".